← Back to Search

HPV game group for Vaccine-Preventable Diseases

N/A
Waitlist Available
Led By ANGELA CHEN, PhD
Research Sponsored by Michigan State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

Study Summary

This trial will study a game-based approach for family members of 11-14 year olds to promote HPV vaccination. The intervention has potential to reduce HPV-associated cancers in youth, with low-cost technology use.

Who is the study for?
This trial is for families with kids aged 11-14 who haven't had their first HPV shot. The child must understand English, and the parent should be over 18, speak English or Spanish, own a smartphone, and agree to participate in study activities and receive texts. Healthcare providers involved need to be over 20 and work at the study sites.Check my eligibility
What is being tested?
The trial is testing an innovative game designed to encourage HPV vaccination among youth. It will assess how well this game works in health clinics, its acceptance by families, any changes it brings about regarding vaccinations, and what factors affect its success.See study design
What are the potential side effects?
Since this intervention involves a game-based educational tool rather than a medical treatment or drug, there are no direct physical side effects expected from participating in this trial.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Child vaccination status (1st & 2nd doses).
Ease of use (intervention arm only)
Intention to vaccinate the child against HPV
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: HPV game groupExperimental Treatment1 Intervention
Parent-child dyads receive a HPV game intervention
Group II: Usual careActive Control1 Intervention
Parent-child dyads receive child's usual care

Find a Location

Who is running the clinical trial?

Michigan State UniversityLead Sponsor
186 Previous Clinical Trials
601,976 Total Patients Enrolled
1 Trials studying Vaccine-Preventable Diseases
180 Patients Enrolled for Vaccine-Preventable Diseases
Arizona State UniversityOTHER
283 Previous Clinical Trials
109,383 Total Patients Enrolled
2 Trials studying Vaccine-Preventable Diseases
130 Patients Enrolled for Vaccine-Preventable Diseases
ANGELA CHEN, PhDPrincipal InvestigatorMichigan State University
1 Previous Clinical Trials
180 Total Patients Enrolled
1 Trials studying Vaccine-Preventable Diseases
180 Patients Enrolled for Vaccine-Preventable Diseases

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research available to those who are younger than 65 years of age?

"This clinical trial's enrollment criteria specifies that applicants must be between the age of 11 and 14. Additionally, there are 25 trials open to those under 18 years old as well as 63 studies for participants over 65."

Answered by AI

Who qualifies for inclusion in this clinical experiment?

"The present clinical trial seeks 131 adolescents between the ages of 11 and 14, who have been diagnosed with vaccine-preventable illnesses."

Answered by AI

Are there any current opportunities to participate in this research?

"Clinicaltrials.gov data suggests that this medical trial, which went live on December 1st 2023 and was last updated on the 7th of December 2023, is not actively recruiting patients at present. Nevertheless, there are 123 other studies accepting participants right now."

Answered by AI
~87 spots leftby Jun 2025